During #ASCOAdvocacySummit we asked lawmakers to prioritize robust funding for @NIH, @theNCI, & @ARPA_H in fiscal year 2027 to support research, maintain the workforce, & drive breakthroughs that improve treatment options. Add your voice ➡️ https://t.co/AIlROM6f2r
“This is the most important thing you’ll do in D.C. and you have to do it with regularity and purpose… There is no one doing more important work than you.” Thanks, @apalmerdc & @JakeSherman for your keynote & insights.
#ASCOAdvocacySummit#CancerCare
So you've heard the practice changing exercise CHALLENGE trial! But what did that groundbreaking exercise program actually look like day-to-day? Let's explore the "Structured Exercise Program" based on info from their paper supplement on NEJM #ASCO2025#ASCO25 1/10
Is 2025 going to be the year Pan-RAS inhibitors make it into the clinic?
Pan-RAS inhibitor shows early/deep molecular response (and 36% response rate) for G12X mutated pancreatic cancer.
(Significant AEs: rash, diarrhea, nausea, vomiting)
https://t.co/34qqj8oqGV